Ticker
PACBCompany Name
PACIFIC BIOSCIENCES OF CALIFORNIA INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -20.02% | $ -152.31M | $ 760.71M |
3/31/2025 | -22.53% | $ -178.13M | $ 790.75M |
12/31/2024 | -18% | $ -212.25M | $ 1.18B |
9/30/2024 | -17.44% | $ -239.56M | $ 1.37B |
6/30/2024 | -18.4% | $ -260.9M | $ 1.42B |
3/31/2024 | -15.77% | $ -249.16M | $ 1.58B |
12/31/2023 | -16.39% | $ -268.02M | $ 1.63B |
9/30/2023 | -16.12% | $ -273.9M | $ 1.7B |
6/30/2023 | -17.42% | $ -275.13M | $ 1.58B |
3/31/2023 | -18.06% | $ -295.71M | $ 1.64B |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for PACIFIC BIOSCIENCES OF CALIFORNIA INC is calculated as follows: FCF [ $ 14.47M ] / Inv. Capital [ $ 172.51M ]
(=) CROIC [ 8.39% ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.3% |
average | 2.78% |
median | 4.97% |
std | 15.04% |